Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Olesya P. Nikolin"'
Autor:
Anatoly I. Martynov, Evgeniya V. Akatova, Elena I. Pervichko, Olesya P. Nikolin, Inna V. Urlaeva
Publikováno v:
КардиоСоматика, Vol 10, Iss 4, Pp 39-43 (2019)
Aim. To study the influence of type of behavioral activity on the development of cardiovascular diseases, to evaluate the effect of type of behavior on the frequency of repeated hospitalizations and fatal outcomes after acute coronary syndrome. Mater
Externí odkaz:
https://doaj.org/article/6e38ea39256f40ecbdbeec4ab2213424
Publikováno v:
КардиоСоматика, Vol 10, Iss 4, Pp 39-43 (2019)
Aim. To study the influence of type of behavioral activity on the development of cardiovascular diseases, to evaluate the effect of type of behavior on the frequency of repeated hospitalizations and fatal outcomes after acute coronary syndrome. Mater
Autor:
A. Martynov, Elena I. Рervichko, Inna V. Urlaeva, Evgeniya V. Akatova, Dentistry, Moscow, Russia, Olesya P. Nikolin
Publikováno v:
Consilium Medicum. :89-94
Publikováno v:
КардиоСоматика, Vol 2, Iss 1, Pp 13-17 (2011)
Summary. Aim. To evaluate the efficiency of placebo-controlled magnerot use on vascular and hemorrhagic manifestations in patients with idiopathic mitral valve prolapse (MVP). Subjects and methods. Seventy-four patients (31,7% males and 68,3% women)
Publikováno v:
Systemic Hypertension. 11
According to the 2013 ESH guidelines, it is possible to use any group of known antihypertensive drugs in the treatment of arterial hypertension. But we often have been using different combinations of drugs. In this situation, using drugs combination
Publikováno v:
Systemic Hypertension. 11
The arterial hypertension takes the basic place among the cardiovascular diseases which are a principal cause of death and invalidity. For today the basic group for treatment of an arterial hypertensia remain angiotensin-converting enzyme inhibitors
Publikováno v:
КардиоСоматика, Vol 2, Iss 1, Pp 13-17 (2011)
Summary. Aim. To evaluate the efficiency of placebo-controlled magnerot use on vascular and hemorrhagic manifestations in patients with idiopathic mitral valve prolapse (MVP). Subjects and methods. Seventy-four patients (31,7% males and 68,3% women)
Externí odkaz:
https://doaj.org/article/60bb225a134f40b0ae95a466652e6777